JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 5 863-866
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lill, D. W.
Right arrow Articles by Darji, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lill, D. W.
Right arrow Articles by Darji, J. T.

Technetium-99m-HMPAO Brain SPECT Evaluation of Neurotoxicity Due to Manganese Toxicity

Duncan W. Lill, James M. Mountz and Jaykrishna T. Darji

University of Alabama School of Medicine and School of Natural Sciences, The Division of Nuclear Medicine, Department of Radiology, University of Alabama at Birmingham Medical Center, Birmingham, Alabama

Correspondence: For correspondence or reprints contact: James M. Mountz, MD, PhD, Division of Nuclear Medicine, University of Alabama Hospital, 619 19th Street South, Birmingham, AL 35233-6835.

ABSTRACT

We performed initial and follow-up regional cerebral blood flow (rCBF) studies using 99mTc-hexamethylpropyleneamine oxime (HMPAO) SPECT on a patient with manganese-induced central nervous system (CNS) neurotoxicity. Methods: The patient had a history of long-term exposure to manganese at the time of the first scan, while the follow-up scan was performed 9 mo after removal from the toxic environment The patient's serum level of manganese was five- to tenfold greater than normal at the time of the initial rCBF brain SPECT scan. Results: The rCBF brain SPECT scan demonstrated significantly decreased rCBF in the right caudate nucleus and both thalami. A MRI scan obtained at the same time was normal. The follow-up rCBF brain SPECT scan was normal. Conclusions: This report supports the utilization of functional rCBF brain SPECT imaging to provide objective evidence of a function CNS abnormality due to neurotoxicity at an early clinical stage. Our results emphasize that rCBF brain SPECT may provide a confirmational test to support the diagnosis of neurotoxicity in the appropriate clinical setting.

Key Words: neurotoxicity • manganese • encephalopathy • SPECT • technetium-99m-HMPAO




This article has been cited by other articles:


Home page
JCOHome page
P. Vera, P. Rohrlich, J. L. Stievenart, M. Elmaleh, M. Duval, F. Bonnin, B. Bok, and E. Vilmer
Contribution of Single-Photon Emission Computed Tomography in the Diagnosis and Follow-Up of CNS Toxicity of a Cytarabine-Containing Regimen in Pediatric Leukemia
J. Clin. Oncol., September 1, 1999; 17(9): 2804 - 2804.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.